Blockchain Registration Transaction Record

Lantern Pharma Launches AI Module predictBBB.ai(TM) with 94% Accuracy

Lantern Pharma introduces predictBBB.ai(TM), an AI module with 94% accuracy in predicting blood-brain barrier permeability, revolutionizing drug development for brain cancers.

This development is a game-changer for the pharmaceutical industry and cancer patients alike. The ability to accurately predict which small molecules can cross the blood-brain barrier opens new avenues for treating brain cancers and neurological disorders, which have historically been difficult to target. With the BBB technologies market poised for significant growth, Lantern Pharma's predictBBB.ai(TM) not only positions the company at the forefront of AI-driven drug development but also promises to accelerate the delivery of life-saving therapies to patients in need.